Samalin Investment Counsel’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Samalin Investment Counsel's AMGN Position: Q2 2026 in Review
Samalin Investment Counsel reduced its Amgen (AMGN) stake by 0.92% in Q2 2026, selling an estimated $6.16K and leaving 1,940 shares worth $703K. The position accounts for 0.22% of the portfolio, ranked #113.
Samalin Investment Counsel first reported a position in AMGN in Q4 2019 and has held it in 24 quarters since. The position peaked at $1.35M in Q3 2024. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Samalin Investment Counsel held 1,940 shares of Amgen worth $703K as of Q2 2026.
- Samalin Investment Counsel sold 18 Amgen shares in Q2 2026, an estimated $6.16K.
- Amgen made up 0.22% of Samalin Investment Counsel's portfolio in Q2 2026, its #113 holding.
- Samalin Investment Counsel first reported a position in Amgen in Q4 2019 and has held it in 24 quarters since.
- Samalin Investment Counsel's Amgen position peaked at $1.35M in Q3 2024.
- 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.